Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings    ZBH

ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Zimmer Biomet Holdings
Zimmer Biomet Holdings specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows:

- reconstruction implants (59.4%): knees replacement (59.2% of net sales), hips replacement (40.8%) ;

- surgical products and traumatology equipment (22.5%);

- spinal implants (9.4%);

- dental implants (5.2%);

- other (3.5%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation.

At the end of 2019, the group had over 20 production sites worldwide.

Net sales break down geographically as follows: Americas (61.1%), Europe/Middle East/Africa (21.9%) and Asia/Pacific (17%).

Number of employees : 19 900 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Knees2,77435%2,81035.2% +1.31%
Hips1,92124.2%1,93524.2% +0.71%
Surgical Sports Medicine, Biologics, Foot and Ankle, Extremities and Trauma1,75222.1%1,79622.5% +2.51%
Spine and Craniomaxillofacial and Thoracic763.909.6%747.309.4% -2.17%
Dental411.205.2%414.005.2% +0.68%
Other310.903.9%280.003.5% -9.94%
Sales per region
2019
USD (in Million)%
United States4,59257.5%
France, Germany, Italy, Spain, United Kingdom960.8012%
EMEA786.109.8%
Asia Pacific720.549%
Japan638.968%
Americas283.703.6%
Managers
NameAgeSinceTitle
Bryan Hanson522017President, Chief Executive Officer & Director
Larry Glasscock712013Non-Executive Chairman
Kenneth Tripp-2018Senior VP-Global Operations & Logistics
Suketu P. Upadhyay492019Executive VP, Chief Financial & Accounting Officer
David J. Kunz-2016VP-Global Quality, Clinical & Regulatory Affairs
Zeeshan Tariq-2016Chief Information Officer & Vice President
Arthur Joseph Higgins642012Independent Director
Robert A. Hagemann622012Independent Director
Betsy J. Bernard632012Independent Director
Christopher B. Begley672015Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 311,078,375 206,926,815 66.5% 103,800,000 33.4% 66.5%
Shareholders
NameEquities%
The Vanguard Group, Inc. 15,138,529 7.31%
Putnam LLC 11,351,865 5.48%
Massachusetts Financial Services Co. 10,152,298 4.90%
Capital Research & Management Co. (Global Investors) 9,806,841 4.74%
SSgA Funds Management, Inc. 8,555,160 4.13%
T. Rowe Price Associates, Inc. (Investment Management) 6,244,231 3.02%
Invesco Advisers, Inc. 6,100,092 2.95%
JPMorgan Investment Management, Inc. 5,960,896 2.88%
BlackRock Fund Advisors 4,859,735 2.35%
Kohlberg Kravis Roberts & Co. LP 3,764,820 1.82%
Markets and indexes
- NYSE
- Main Market
- SP 500 /
Stock Exchange Codes
- Bloomberg Code :  ZBH:US
- Reuters Code :  ZBH.N
- Datastream Code :  
Company contact information
Zimmer Biomet Holdings
345 Street East Main
PO Box 708
IN 46580 Warsaw, Indiana
États-Unis (les)

Phone : +1 574 267 6131
Fax : +1 574 372 4988
web site : http://investor.zimmerbiomet.com
Sector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS-2.39%30 283
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
BECTON, DICKINSON AND COMPANY-13.65%68 111
HOYA CORPORATION33.11%49 894
BAXTER INTERNATIONAL INC.-9.03%38 858
ALIGN TECHNOLOGY, INC.79.22%37 950
SARTORIUS STEDIM BIOTECH98.38%33 382
DEXCOM, INC.49.82%30 698
TERUMO CORPORATION6.74%30 026
SYSMEX CORPORATION46.73%21 881
AMERISOURCEBERGEN CORPORATION21.38%21 060
WEST PHARMACEUTICAL SERVICES, INC.84.90%20 342
STERIS PLC27.16%16 537
BIO-RAD LABORATORIES, INC.45.53%16 074
AVANTOR, INC.50.30%15 777
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED59.95%14 520
LIVONGO HEALTH, INC.457.74%14 020
DENTSPLY SIRONA INC.-10.07%11 122
REPLIGEN CORPORATION105.05%9 998
DEMANT A/S12.01%9 040